Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX

Point72 Asset Management, L.P. reported a 5.60% stake in Amylyx Pharmaceuticals, Inc. (Schedule 13G)

Event Jan 13, 2025 · Filed Jan 14, 2025

Point72 Asset Management, L.P. reported a 5.60% stake in Amylyx Pharmaceuticals, Inc., 4,820,333 shares, as a passive investor on Jan 13, 2025. Filed Jan 14, 2025 (Schedule 13G).

Stake
5.60%
Shares
4,820,333
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.5.60%4,820,333
Point72 Capital Advisors, Inc.5.60%4,820,333
Steven A. Cohen5.60%4,820,333

Source

View original at SEC

Related